http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2007524617-A
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-428 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D277-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-428 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-425 |
| filingDate | 2004-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2007-08-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | JP-2007524617-A |
| titleOfInvention | Methods for inhibiting or reversing tau filament fibrosis |
| abstract | Methods are provided for inhibiting and / or reversing tau filament formation or fibrosis. These methods can be used to treat certain neurological disorders in vivo by administering a pharmaceutical composition that inhibits and / or reverses tau filament formation or fibrosis. Preferred compositions include 3- (2-hydroxyethyl) -2- [2-[[3- (2-hydroxyethyl) -5-methoxy-2-benzothiazolylidene] methyl] -1-butenyl]- 5-methoxybenzothiazolium is included. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013542993-A |
| priorityDate | 2003-06-19-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 194.